Package 64764-800-28

{"route": ["ORAL"], "spl_id": "14acb19d-0258-47df-a01a-bdca1ea05e54", "openfda": {"nui": ["N0000193976", "N0000193977", "N0000182141", "N0000185503", "N0000190113"], "unii": ["PTB4X93HE1"], "rxcui": ["2586073", "2586079"], "spl_set_id": ["c94fc2c5-e840-4f18-b7d8-d5eacb26d3a0"], "pharm_class_epc": ["Cytomegalovirus pUL97 Kinase Inhibitor [EPC]"], "pharm_class_moa": ["Cytomegalovirus pUL97 Kinase Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]", "Breast Cancer Resistance Protein Inhibitors [MoA]"], "manufacturer_name": ["Takeda Pharmaceuticals America, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE in 1 CARTON (64764-800-28)  / 28 TABLET, COATED in 1 BOTTLE", "package_ndc": "64764-800-28", "marketing_start_date": "20211123"}, {"sample": false, "description": "1 BOTTLE in 1 CARTON (64764-800-56)  / 56 TABLET, COATED in 1 BOTTLE", "package_ndc": "64764-800-56", "marketing_start_date": "20211123"}], "brand_name": "Livtencity", "product_id": "64764-800_14acb19d-0258-47df-a01a-bdca1ea05e54", "dosage_form": "TABLET, COATED", "pharm_class": ["Breast Cancer Resistance Protein Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "Cytomegalovirus pUL97 Kinase Inhibitor [EPC]", "Cytomegalovirus pUL97 Kinase Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "product_ndc": "64764-800", "generic_name": "MARIBAVIR", "labeler_name": "Takeda Pharmaceuticals America, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Livtencity", "active_ingredients": [{"name": "MARIBAVIR", "strength": "200 mg/1"}], "application_number": "NDA215596", "marketing_category": "NDA", "marketing_start_date": "20211123", "listing_expiration_date": "20271231"}